Accepted abstracts are to be considered for oral or poster presentation.
Abstract submission deadline: March 20th, 2025.
Abstract acceptance notification: March 22nd, 2025.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
Abstract International Committee
Head of research department.
Gustave Roussy France
Head of International Academic Network, Gustave Roussy Institute, France
ISCO 2024 Abstract Winners:
Mohamed Ahmed Mansour
Abstract Title
Management and Outcome of Ewing Sarcoma in Pediatric Patients: A Single-Centre Experience.
Taha Abd-ElSalam
Abstract Title
Primed for death: Prognostic Role of BH3--Only Proteins in Breast Cancer Therapy: A Systematic and Meta-Analysis Review.
Haytham Abdelkader
Abstract Title
A Retrospective Clinicopathological Analysis for Cases of Double Primary Malignancies.
Nahla Ali
Abstract Title
Survival Analysis of Cutaneous Malignant Melanoma in the Pediatric Age Group: a SEER Based Study.
Nour ElHuda Hassan
Abstract Title
The Added Values of Contrast Enhanced Digital Mammography (CEDM) In the Evaluation of Indeterminate Breast Lesions.
ISCO 2023 Abstract Winners:
Ahmed Soliman
Abstract Title
Concurrent Chemoradiotherapy versus Neoadjuvant Chemotherapy Followed by Radical Hysterectomy for FIGO stage IIB Cervical Cancer Patients: A Systematic Review and Meta-analysis.
Ola Abou Elsoud
Abstract Title
The prolonged effect of Nivolumab as a second-line option in non-small-cell lung cancer patients after treatment discontinuation.
Dina Mohyeldeen
Abstract Title
Proton Pump Inhibitors Reduce Survival Outcomes in Patients Treated with Capecitabine: Meta-analysis.